The United States banned local companies, including Synopsys, from selling chip design software to China at the end of May. Following reports of the U.S. strengthening export controls on chips to China, the State Administration for Market Regulation of China postponed the approval of the merger transaction involving Synopsys and ANSYS, which is valued at $35 billion. The transaction had previously received support from U.S. and European authorities and was expected to be completed by the end of this month.
Reports indicate that if Synopsys can present a plan to alleviate the concerns of the State Administration for Market Regulation, the transaction may still be approved. There are also reports suggesting that the extension of the approval time by the market regulation authority is due to the complexity of the transaction itself and is not directly related to the trade war

ANSS

SNPS

China has postponed the approval of the $35 billion merger deal between Synopsys and Ansys due to U.S. export controls on chips. The deal had originally received support from U.S. and European authorities and was expected to be completed by the end of this month. If Synopsys can propose a plan to alleviate regulatory concerns, the deal may still be approved. The extension of the approval by the State Administration for Market Regulation is related to the complexity of the transaction, rather than being directly caused by the trade war

据报中国因美国晶片出口管制延迟审批新思科技 (Synopsys) 并购交易